Ge Yang

4.7k total citations
9 papers, 120 citations indexed

About

Ge Yang is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ge Yang has authored 9 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ge Yang's work include Alzheimer's disease research and treatments (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). Ge Yang is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). Ge Yang collaborates with scholars based in Germany, China and United States. Ge Yang's co-authors include Shermali Gunawardena, Lawrence S.B. Goldstein, Jörg Labahn, Jan Kubíček, Hongzhi Tang, Karolina Corin, Shuguang Zhang, Barbara Maertens, Thomas Schubert and Fei Tao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Ge Yang

9 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ge Yang Germany 4 76 32 31 25 10 9 120
Zizheng Li United States 7 128 1.7× 77 2.4× 17 0.5× 37 1.5× 10 1.0× 14 202
Hamad Yadikar Kuwait 7 104 1.4× 35 1.1× 14 0.5× 13 0.5× 5 0.5× 9 167
Gregory M. Rosenberg United States 6 109 1.4× 98 3.1× 17 0.5× 21 0.8× 22 2.2× 8 169
Shenqing Zhang China 9 142 1.9× 61 1.9× 16 0.5× 19 0.8× 8 0.8× 15 229
Christian Heid Germany 6 128 1.7× 23 0.7× 21 0.7× 15 0.6× 2 0.2× 6 188
Mara Zilocchi Canada 7 126 1.7× 34 1.1× 36 1.2× 10 0.4× 9 0.9× 15 212
Gabriel Boyle United States 5 74 1.0× 46 1.4× 26 0.8× 8 0.3× 6 0.6× 8 157
Thawfeek Varusai United Kingdom 7 79 1.0× 14 0.4× 14 0.5× 8 0.3× 11 1.1× 7 117
Joerg Weiske Germany 2 50 0.7× 41 1.3× 17 0.5× 11 0.4× 9 0.9× 2 87
Arthur Viodé United States 9 83 1.1× 50 1.6× 16 0.5× 6 0.2× 8 0.8× 13 188

Countries citing papers authored by Ge Yang

Since Specialization
Citations

This map shows the geographic impact of Ge Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Yang more than expected).

Fields of papers citing papers by Ge Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Yang. The network helps show where Ge Yang may publish in the future.

Co-authorship network of co-authors of Ge Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Yang. A scholar is included among the top collaborators of Ge Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Yang. Ge Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Guo, Xiangyu, et al.. (2025). Potential Biomarkers and Treatment of Neuroinflammation in Parkinson's Disease. Actas Españolas de Psiquiatría. 53(1). 181–188. 4 indexed citations
2.
Guo, Xiangyu, et al.. (2025). Crosstalk between neuroinflammation and ferroptosis: Implications for Parkinson’s disease progression. Frontiers in Pharmacology. 16. 1528538–1528538. 2 indexed citations
3.
Pan, Yue, Qiang Yu, Ningyuan Wang, et al.. (2023). A New Method of Plane-Wave Ultrasound Imaging Based on Reverse Time Migration. IEEE Transactions on Biomedical Engineering. 71(5). 1628–1639. 1 indexed citations
4.
Yang, Ge, et al.. (2018). Data on solubilization, identification, and thermal stability of human Presenilin-2. Data in Brief. 17. 626–630. 1 indexed citations
5.
Zhang, Shuguang, Fei Tao, Rui Qing, et al.. (2018). QTY code enables design of detergent-free chemokine receptors that retain ligand-binding activities. Proceedings of the National Academy of Sciences. 115(37). E8652–E8659. 48 indexed citations
6.
Yang, Ge, et al.. (2017). High-efficient production and biophysical characterisation of nicastrin and its interaction with APPC100. Scientific Reports. 7(1). 44297–44297. 6 indexed citations
7.
Yang, Ge, et al.. (2017). Influence of solubilization and AD-mutations on stability and structure of human presenilins. Scientific Reports. 7(1). 17970–17970. 3 indexed citations
8.
Yang, Ge, et al.. (2017). Expression, purification, and preliminary characterization of human presenilin-2. Process Biochemistry. 64. 63–73. 2 indexed citations
9.
Gunawardena, Shermali, Ge Yang, & Lawrence S.B. Goldstein. (2013). Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo. Human Molecular Genetics. 22(19). 3828–3843. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026